603939 益丰药房
2025/03 - 三个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入6,009,0440.64%24,062,15522,588,22719,886,39615,326,305
减:营业总成本5,391,078-0.06%21,973,89320,616,59718,008,27514,045,641
    其中:营业成本3,627,193-0.01%14,408,31113,957,59912,025,5649,142,818
               财务费用41,29647.49%173,90386,185104,812114,870
               资产减值损失(22,764)17.94%(102,396)(72,634)(56,019)(40,746)
公允价值变动收益------------
投资收益27,18682.09%108,12942,3726,86934,368
    其中:对联营企业和合营企业的投资收益----(1)317(11)--
营业利润650,5429.61%2,203,8242,054,7851,885,5331,338,867
利润总额647,8299.20%2,182,4472,037,5941,877,4871,337,906
减:所得税费用154,2804.75%529,665456,663454,061347,157
净利润493,54910.67%1,652,7821,580,9311,423,426990,749
减:非控股权益44,05612.39%124,206168,946161,585102,864
股东净利润449,49410.51%1,528,5771,411,9851,261,841887,884

市场价值指针
每股收益 (元) *0.37012.12%1.2601.1701.2601.250
每股派息 (元) *----0.6500.5000.4000.300
每股净资产 (元) *9.043-10.16%8.6649.70211.85510.409
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容